# EDGAR Filing Document

**Accession Number:** 0001220754
**File Stem:** 0001220754-25-000048
**Filing Date:** 2025-7
**Character Count:** 9813
**Document Hash:** 2d029ebc51bb8d32709e67d912fae6c2
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001220754-25-000048.hdr.sgml**: 20250710

**ACCESSION NUMBER**: 0001220754-25-000048

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 14

**CONFORMED PERIOD OF REPORT**: 20250707

**ITEM INFORMATION**: Regulation FD Disclosure

**ITEM INFORMATION**: Other Events

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20250710

**DATE AS OF CHANGE**: 20250709

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** ModivCare Inc
- **CENTRAL INDEX KEY:** 0001220754
- **STANDARD INDUSTRIAL CLASSIFICATION:** TRANSPORTATION SERVICES [4700]
- **ORGANIZATION NAME:** 01 Energy & Transportation
- **EIN:** 860845127
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-34221
- **FILM NUMBER:** 251114470

**BUSINESS ADDRESS:**
- **STREET 1:** 6900 LAYTON AVENUE
- **STREET 2:** 12TH FLOOR
- **CITY:** DENVER
- **STATE:** CO
- **ZIP:** 80237
- **BUSINESS PHONE:** 720-258-2130

**MAIL ADDRESS:**
- **STREET 1:** 6900 LAYTON AVENUE
- **STREET 2:** 12TH FLOOR
- **CITY:** DENVER
- **STATE:** CO
- **ZIP:** 80237

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** PROVIDENCE SERVICE CORP
- **DATE OF NAME CHANGE:** 20030226

?xml version='1.0' encoding='ASCII'? prsc-20250707

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**WASHINGTON, D.C. 20549**

**FORM 8-K**

**CURRENT REPORT**

**PURSUANT TO SECTION 13 OR 15(d) OF THE**

**SECURITIES EXCHANGE ACT OF 1934**

**Date of Report (Date of earliest event reported): July 7, 2025**

**ModivCare Inc.**

**(Exact name of registrant as specified in its charter)**

---

| | | |
|:---|:---|:---|
| **Delaware** | **001-34221** | **86-0845127** |
| (State or other jurisdiction of<br>incorporation or organization) | (Commission File Number) | (I.R.S. Employer<br>Identification No.) |

---

---

| | | |
|:---|:---|:---|
| **6900 E. Layton Avenue,** | **12th Floor** | |
| **Denver,** | **Colorado** | **80237** |
| (Address of principal executive offices) | (Address of principal executive offices) | (Zip Code) |

---

**(720) 258-2130**

Registrant's telephone number, including area code:

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| Title of each class | Trading Symbol(s) | Name of exchange on which registered |
| Common Stock, $0.001 par value per share | MODV | The NASDAQ Global Select Market |

---

◻ Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

---

| | |
|:---|:---|
| Emerging growth company | ☐ |
| If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  | ◻ |

---

------

---

| | |
|:---|:---|
| **Item 7.01** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Regulation FD Disclosure.** |

---

On July 10, 2025, ModivCare Inc. (the "Company") issued a press release announcing that it has regained compliance with Rule 5450(b)(3)(C) of the Nasdaq Stock Market LLC ("Nasdaq") regarding the Company's market value of publicly held shares ("MVPHS"), with the result that the Company again satisfies all Nasdaq listing standards required for continued listing on The Nasdaq Global Select Market. A copy of the press release is furnished as Exhibit 99.1 hereto and incorporated herein by reference.

---

| | |
|:---|:---|
| **Item 8.01** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Other Events.** |

---

On July 7, 2025, the Company received written notice from the Listing Qualifications Department of Nasdaq informing the Company that it regained compliance with the minimum $15,000,000 MVPHS required for continued listing on The Nasdaq Global Select Market under Nasdaq Listing Rule 5450(b)(3)(C), having confirmed that the Company's MVPHS had been above $15,000,000 for at least the last 20 consecutive business days. Accordingly, the Company again satisfies all NASDAQ listing requirements for continued listing on the Nasdaq Global Select Market and this matter has been closed.

---

| | |
|:---|:---|
| **Item 9.01** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Financial Statements and Exhibits.** |

---

(d) Exhibits.

---

| | |
|:---|:---|
| **Exhibit <br>Number** | **Description** |
| 99.1 | <u>[Press Release dated July 10, 2025](a-ex991xrecompliancewithna.htm)</u> |
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) |

---

------

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | | |
|:---|:---|:---|
| | ModivCare Inc. | ModivCare Inc. |
| Date: July 10, 2025 | By: | /s/ Faisal Khan |
|  | Name: | Faisal Khan |
|  | Title: | Senior Vice President, General Counsel and Secretary |

---

## Exhibit 99.1

![image_0.jpg](image_0.jpg)

**Modivcare Regains Compliance with Nasdaq Continued Listing Standard**

**Denver, CO – July 10, 2025** – Modivcare Inc. (the "Company" or "Modivcare") (Nasdaq: MODV), a technology-enabled healthcare services company that provides a platform of integrated supportive care solutions focused on improving health outcomes, today announced it has regained compliance with Rule 5450(b)(3)(C) of the Nasdaq Stock Market LLC ("Nasdaq") regarding the Company's market value of publicly held shares ("MVPHS").

On July 7, 2025, the Company received confirmation from Nasdaq that it regained compliance with the MVPHS requirement for continued listing on Nasdaq, having confirmed that the Company's MVPHS had been above $15 million for at least the last 20 consecutive business days. Accordingly, the Company again satisfies all Nasdaq listing standards required for continued listing on The Nasdaq Global Select Market.

"We are pleased to regain full compliance with Nasdaq listing standards, and to have achieved this by means of stock performance and appreciation," said L. Heath Sampson, President and CEO. "We are continuing our efforts to enhance enterprise value and build a stronger, more connected Modivcare."

ModivCare will continue to be traded on The Nasdaq Global Select Market, subject to its continued compliance with all applicable listing requirements.

**About Modivcare**

Modivcare Inc. ("Modivcare") is a technology-enabled healthcare services company that provides a suite of integrated supportive care solutions for public and private payors and their members. Modivcare's value-based solutions address the social determinants of health (SDoH) by connecting members to essential care services. By doing so, Modivcare helps health plans manage risks, reduce costs, and improve health outcomes. Modivcare serves as a provider of non-emergency medical transportation (NEMT), personal care services (PCS), and in-home monitoring solutions (Monitoring). To learn more about Modivcare, please visit www.modivcare.com.

**Forward-Looking Statements** 

Certain statements contained in this press release constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are predictive in nature and are frequently identified by the use of terms such as "may," "will," "should," "expect," "believe," "estimate," "intend," and similar words indicating possible future expectations, events or actions. Such forward-looking statements are based on current expectations, assumptions, estimates and projections about our business and our industry, and are not guarantees of our future performance. These statements are subject to a number of known and unknown risks, uncertainties and other factors, many of which are beyond our ability to control or predict, which may cause actual results to be materially different from those expressed or implied herein. The Company has provided additional information about the risks facing its business in its most recent annual report on Form 10-K and any subsequent periodic and current reports on Forms 10-Q and 8-K filed by it with the Securities and Exchange Commission. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date the statement was made and are expressly qualified in their entirety by the cautionary statements set forth herein and in our filings with the Securities and Exchange Commission, which you should read in their entirety before making an investment decision with respect to our securities. We undertake no obligation to update or revise any forward-looking statements contained in this release, whether as a result of new information, future events or otherwise, except as required by applicable law.

**Investor Relations Contact**

ICR Healthcare

ModivcareIR@icrhealthcare.com

<br>